NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients

  • Sunny Malhotra
  • , Carme Costa
  • , Herena Eixarch
  • , Christian W. Keller
  • , Lukas Amman
  • , Helios Martínez-Banaclocha
  • , Luciana Midaglia
  • , Eduard Sarró
  • , Isabel Machín-Díaz
  • , Luisa M. Villar
  • , Juan Carlos Triviño
  • , Begoña Oliver-Martos
  • , Laura Navarro Parladé
  • , Laura Calvo-Barreiro
  • , Fuencisla Matesanz
  • , Koen Vandenbroeck
  • , Elena Urcelay
  • , María Luisa Martínez-Ginés
  • , Amalia Tejeda-Velarde
  • , Nicolás Fissolo
    • Joaquín Castilló, Alex Sanchez, Avril A.B. Robertson, Diego Clemente, Marco Prinz, Pablo Pelegrin, Jan D. Lünemann, Carmen Espejo, Xavier Montalban, Manuel Comabella

Research output: Contribution to journal › Article › peer-review

117 Scopus citations

Fingerprint

Dive into the research topics of 'NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients'. Together they form a unique fingerprint.

Keyphrases

Immunology and Microbiology